Epidemiology of Sjögren syndrome

被引:37
|
作者
Beydon, Maxime [1 ]
McCoy, Sara [2 ]
Nguyen, Yann [1 ,3 ]
Sumida, Takayuki [4 ]
Mariette, Xavier [1 ,3 ]
Seror, Raphaele [1 ,3 ]
机构
[1] Univ Paris Saclay, Bicetre AP HP Hop, Dept Rheumatol, Paris, France
[2] Univ Wisconsin Madison, Dept Med, Madison, WI USA
[3] Univ Paris Saclay, Ctr Immunol Viral Infect & Autoimmune Dis, INSERM U1184, Le Kremlin Bicetre, France
[4] Univ Tsukuba, Dept Internal Med, Tsukuba, Japan
关键词
PRIMARY SJOGRENS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NON-HODGKIN-LYMPHOMA; QUALITY-OF-LIFE; AUTOIMMUNE RHEUMATIC-DISEASES; CLASSIFICATION CRITERIA; SICCA SYMPTOMS; CLINICAL CHARACTERISTICS; FOLLOW-UP; INTERNATIONAL-CLASSIFICATION;
D O I
10.1038/s41584-023-01057-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjogren syndrome or in association with other connective tissue diseases (CTDs), including rheumatoid arthritis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The estimation of the prevalence and incidence of Sjogren syndrome varies depending on diagnostic criteria and study design, making it difficult to estimate geographical and temporal trends. Nonetheless, disease phenotype is influenced by geographical origin, which is a risk factor for systemic activity. Whether mortality in primary Sjogren syndrome is increased compared with that of the general population is not yet known, but extra-glandular manifestations, in particular lymphomas, are clear risk factors for mortality. In CTDs associated with Sjogren syndrome, lymphoma risk seems higher than that of patients with CTD alone, and there is potentially lower disease activity in SLE with Sjogren syndrome and in SSc with Sjogren syndrome than in SLE or SSc alone. In this epidemiological Review, the authors summarize the available evidence relating to the prevalence, incidence, risk factors and mortality associated with the autoimmune disorder Sjogren syndrome, with or without the co-occurrence of other connective tissue diseases. Primary Sjogren syndrome (pSS) affects mostly women, with age at disease onset as well as systemic activity varying according to geographical origin.Assessment of the prevalence of pSS varies according to study methodology, but can be estimated at between 0.01% and 0.05%, although some countries might be under-represented in this estimation.Mortality in pSS seems to be elevated predominantly in patients with extra-glandular manifestations, pulmonary involvement and non-Hodgkin lymphoma.pSS is the autoimmune disease with the most important increased risk of non-Hodgkin lymphoma, especially among patients with extra-glandular manifestations or systemic activity, low complement levels, cryoglobulinaemic vasculitis or rheumatoid factor positivity.Sjogren syndrome can be associated with other connective tissue diseases, mainly rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
引用
收藏
页码:158 / 169
页数:12
相关论文
共 50 条
  • [41] Gynecological symptoms in primary and secondary Sjögren's syndrome and the effect of the disease on sexuality
    Ozdemir Isik, Ozlem
    Temiz Karadag, Duygu
    Tekeoglu, Senem
    Yazici, Ayten
    Cefle, Ayse
    JOURNAL OF SEXUAL MEDICINE, 2024, 21 (03) : 248 - 254
  • [42] Association Between Quantitative Sialoscintigraphy and Antibody Profiles in Patients With Sjögren or Sicca Syndrome
    Chuang, Tzyy-Ling
    Koo, Malcolm
    Lee, Yi-Min
    Tung, Chien-Hsueh
    Wang, Yuh-Feng
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : 109 - 118
  • [43] MALT-Lymphom des Larynx bei bekanntem Sjögren-SyndromLaryngeal MALT lymphoma with known Sjögren syndrome
    M. Fischer
    I.-S. Horn
    J. Bertolini
    S. Dietzsch
    M. Fuchs
    A. Dietz
    HNO, 2011, 59 (1) : 111 - 114
  • [44] Disease Duration Affects the Clinical Phenotype of Primary Sjögren Syndrome: A Medical Records Review Study of 952 Cases
    Zhang, Yan
    Yang, Jian-Ying
    Chen, Jia-Qi
    Liao, Jia-He
    Huang, Zi-Wei
    Wu, Tzu-Hua
    He, Qian
    Yu, Xin-Bo
    Wang, Qin
    Song, Wei-Jiang
    Luo, Jing
    Tao, Qing-Wen
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (04) : 151 - 158
  • [45] Manifestations and management of Sjögren's disease
    Maleki-Fischbach, Mehrnaz
    Kastsianok, Liudmila
    Koslow, Matthew
    Chan, Edward D.
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [46] CTLA4 polymorphism and primary Sjögren's syndrome
    Susan Lester
    Sarah Downie-Doyle
    Maureen Rischmueller
    Arthritis Research & Therapy, 9
  • [47] Nutrient intake in women with primary and secondary Sjögren's syndrome
    J M Cermak
    A S Papas
    R M Sullivan
    M R Dana
    D A Sullivan
    European Journal of Clinical Nutrition, 2003, 57 : 328 - 334
  • [48] Characteristics of the oral microbiota in patients with primary Sjögren's syndrome
    Xie, Yiwen
    Fan, Yu
    Su, Miaotong
    Wang, Yukai
    Zhang, Guohong
    CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 1939 - 1947
  • [50] Invisible, Uncontrollable, Unpredictable: Illness Experiences in Women with Sjögren Syndrome
    Herrera, Andrea
    Leiva, Loreto
    Espinoza, Iris
    Rios-Erazo, Matias
    Shakhtur, Nailah
    Wurmann, Pamela
    Rojas-Alcayaga, Gonzalo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)